Our 2026 Hiring Report is out — see what 146,050 job postings say about getting hired.

Read the report →
JOB DETAILS

Director, Regulatory Affairs

CompanyViking Therapeutics, Inc.
LocationSan Diego
Work ModeOn Site
PostedAugust 25, 2026
About The Company
Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development of novel first-in-class or best-in-class therapies for the treatment of metabolic and endocrine disorders. Viking's research and development activities leverage its expertise in metabolism to develop innovative therapeutics designed to improve patients' lives. Viking's clinical programs include VK2735, a novel dual agonist of the glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors for the potential treatment of various metabolic disorders. The company is evaluating its subcutaneous formulation of VK2735 in a Phase 3 obesity program that includes two Phase 3 clinical trials (VANQUISH-1 and VANQUISH-2). Data from a Phase 1 and a Phase 2 trial evaluating subcutaneous VK2735 demonstrated an encouraging safety and tolerability profile as well as positive signs of clinical benefit. Concurrently, the company is evaluating an oral formulation of VK2735 in obesity. Viking is also developing VK2809, a novel, orally available, small molecule selective thyroid hormone receptor beta agonist for the treatment of lipid and metabolic disorders. The compound successfully achieved both the primary and secondary endpoints in a Phase 2b study for the treatment of biopsy-confirmed non-alcoholic steatohepatitis (NASH) and fibrosis. The company's newest program is evaluating a series of internally developed dual amylin and calcitonin receptor agonists (or DACRAs) for the treatment of obesity and other metabolic disorders. In the rare disease space, Viking is developing VK0214, a novel, orally available, small molecule selective thyroid hormone receptor beta agonist for the potential treatment of X-linked adrenoleukodystrophy (X-ALD).
About the Role

Description

The Director of Regulatory Affairs (RA Director) will manage, evaluate, and execute regulatory projects consistent with company goals, and will contribute to the development of global regulatory strategy. This position will directly support the drafting and filing of a NDA.  The RA Director is responsible for maintaining electronic regulatory files, reviewing, and overseeing the production of CMC, nonclinical, clinical and regulatory documents in support of investigational and marketing applications, representing Regulatory in cross-functional teams, and directing the day-to-day activities of the external publishing and consulting vendors that support the function.


The Vice President of Regulatory Affairs retains overall accountability for program-level regulatory strategy. Within that framework, the RA Director is expected to contribute substantively to strategy discussions and then to execute the resulting work directly — including detailed review and quality control of submission documents, maintenance of submission content plans and regulatory records, and hands-on coordination of the outsourced publishing vendor. This is a working role within a lean, virtual-sponsor operating model. 


Essential Duties and Responsibilities

The Regulatory Affairs responsibilities of this role include but are not limited to the following:

  • Coordinate and execute the planning, content development, and delivery of global regulatory submissions (especially the upcoming NDA filing) and life cycle management, ensuring that submissions are in support of company goals, of the highest quality, and delivered on-time.
  • Perform detailed review and quality control of submission documents and components prior to release for publishing, assessing scientific accuracy, internal consistency across documents, regulatory compliance, and correctness of cross-references and citations.
  • Manage component handoffs and publishing timelines, review draft published output, resolve hyperlinking, bookmarking, PDF specification, and validation findings, confirm sequence numbering and lifecycle operators, and verify successful transmission and receipt through the FDA Electronic Submissions Gateway.
  • Maintain regulatory records, submission archives, health authority correspondence logs, and tracking of regulatory commitments and agreements.
  • Represent Regulatory in cross-functional teams and provide guidance to teams on the regulatory requirements and risk(s) to support clinical development programs including preparation and maintenance of e.g., IND, CTA, NDA, MAA, and IMPD filings.
  • Develop, review and/or file INDs, CTAs, NDAs, briefing documents including authoring, reviewing, and/or managing the development of DSURs, annual reports, CSRs, Protocols, Investigator Brochures, pediatric study plans (iPSP/PIP), Module 2 summaries, amendments, and other documents as needed. 
  • Support preparation for health authority interactions, including meeting requests, question development, briefing package assembly and authoring, and rehearsal logistics; participate in meetings with FDA and other agencies as a functional contributor.
  • Collaboratively develop global regulatory strategies to support CMC, nonclinical, and clinical activities across various development programs.
  • Contribute to the development of product labeling, including USPI and associated patient labeling, and support labeling review and negotiation activities.
  • Conduct regulatory research, analyze, strategize, and communicate recommendations regarding new/emerging regulations and development issues as they arise to management and project teams as needed. Perform precedent analysis using publicly available regulatory records (e.g., approval packages, review memoranda, advisory committee materials, and approved labeling).
  • Identify and escalate regulatory risks and issues to the Vice President of Regulatory Affairs with supporting analysis, available options, and proposed mitigations, distinguishing clearly between what guidance and precedent support and what remains unsettled.
  • Support inspection readiness activities, including pre-approval inspection (PAI) and BIMO preparation across the Company and its contracted CROs and CMOs.
  • Collaborate with and supervise contributions from contractors and vendors. Define scope of work, track spend against budget, review deliverables on receipt, and hold medical writing, publishing, and regulatory consulting partners accountable for quality and timeliness.
  • Other duties as assigned.

Requirements

Education and Experience

  • Bachelor's degree in a scientific discipline required; advanced degree (MS, PhD, PharmD, or equivalent) preferred.
  • Minimum of 8 years of pharmaceutical or biotechnology industry experience, including at least 6 years in Regulatory Affairs. An advanced degree may substitute for up to two years of experience (6+ years industry / 4+ years Regulatory Affairs).
  • Current, hands-on experience preparing, authoring, and reviewing regulatory submission content. The successful candidate will be comfortable working at the document level and will not depend on others to produce or quality-check deliverables.
  • Demonstrated experience contributing to at least one NDA, BLA, or MAA; experience supporting an application through an approval cycle is preferred.
  • Experience preparing briefing packages and supporting formal health authority meetings (e.g., Type A, Type B, Type C, and Type D).
  • Experience and knowledge in preparation of INDs and NDAs, and supportive amendments and supplements (manufacturing, nonclinical, clinical) including hands-on experience with eCTD.
  • Demonstrated experience with electronic  submissions to FDA, including working familiarity with eCTD validation criteria, PDF and hyperlinking specifications, submission lifecycle operators, and gateway transmission.
  • Working knowledge of GMP, GLP, and GCP regulations as well as an understanding of the pharmaceutical product life cycle.
  • Working knowledge of FDA and ICH regulatory guidance and regulations. Working knowledge of 21 CFR Parts 312 and 314, ICH E6 and M4 (CTD), and PDUFA review procedures and goal dates.
  • Experience at a small or mid-size sponsor operating through external CROs, CMOs, and consultants (lean or virtual operating model) is strongly preferred.
  • Experience in metabolic, endocrine, or cardiometabolic therapeutic areas, or with peptide therapeutics, is preferred.
  • Regulatory Affairs Certification (RAC) is a plus.

Knowledge and Skills

  • High degree of proficiency in the Microsoft Office Suite (i.e., Word, PowerPoint, etc.), Outlook Internet applications, WebEx, Zoom. Advanced Word skills, including styles, tracked changes, cross-references, and template management.
  • Working proficiency with regulatory information management, document management, and electronic publishing systems (e.g., Veeva Vault RIM, Lorenz docuBridge, or comparable), and with secure agency correspondence methods.
  • High attention to detail and excellent proofreading and editing skills. Ability to verify citations to guidance, regulation, and precedent to an audit-ready standard.
  • Drug-device combination product experience under 21 CFR Part 4, including autoinjector or pen presentations and the interfaces with human factors engineering and design control, is preferred.
  • Strong analytical, interpersonal, and well-developed problem-solving skills with the ability to work in a positive and collaborative fashion.
  • Ability to contribute substantively to regulatory strategy discussions and to articulate a supported position clearly and concisely to management.
  • Willingness to move fluidly between strategic discussion and detailed execution. 
  • Ability to work independently with minimal supervision, prioritize across concurrent programs and competing deadlines, and drive work to completion in a fast-paced, resource-constrained environment.
  • Team player with excellent written and verbal communication skills.
  • Ability to work on-site at the Company's San Diego, California headquarters.

 

VIKING THERAPEUTICS

Viking Therapeutics, Inc., is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status. Viking Therapeutics also complies with all applicable national, state and local laws governing nondiscrimination in employment as well as work authorization and employment eligibility verification requirements of the Immigration and Nationality Act and IRCA.


Notice to Agency and Search Firm Representatives

Viking Therapeutics, Inc. is not accepting unsolicited resumes from agencies and/or search firms for this job posting. Resumes submitted to any Viking employee by a third-party agency and/or search firm without a valid written & signed search agreement, and assignment of specific position, will become the sole property of Viking Therapeutics, Inc. No fee will be paid if a candidate is hired for this position as a result of an unsolicited agency or search firm referral.


Salary Description

$190,000.00 - $210,000.00 annual salary

#li-dni


Key Skills
Regulatory AffairsNDA FilingeCTDFDA Electronic Submissions GatewayCMCClinical DevelopmentRegulatory StrategyQuality ControlProject ManagementRegulatory ComplianceINDCTAMAALabelingRisk ManagementVeeva Vault RIM
Categories
HealthcareScience & ResearchManagement & LeadershipConsulting
Job Information
📋Core Responsibilities
The Director of Regulatory Affairs will manage and execute global regulatory projects, including the drafting and filing of NDAs. They are responsible for overseeing cross-functional teams, maintaining regulatory records, and ensuring high-quality submission documents.
📋Job Type
full time
💰Salary Range
$190,000 - $210,000
📊Experience Level
10+
💼Company Size
70
📊Visa Sponsorship
No
💼Language
English
🏢Working Hours
40 hours
Apply Now →

You'll be redirected to
the company's application page